Chesapeake Midstream Partners, L.p (CHKM) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $0.29 per share, and the company reported $0.34 per share. Actual earnings beat estimated earnings by $0.05 per share. Investors might expect the stock price to increase as results were better than expected. Further analysis may need to be done to determine whether the upswing will come to effect. Guidance and revenue estimates must be taken into consideration. Shares of CHKM fell by 0.56% or $-0.14/share to $25.01. In the past year, the shares have traded as low as $23.93 and as high as $29.31. On average, 264918 shares of CHKM exchange hands on a given day and today's volume is recorded at 36266.
Acelrx Pharmaceuticals, Inc (ACRX) reported earnings results for the quarter ended September 2011. The company reported $-0.3 per share when analysts were expecting earnings of $-0.34. Earnings beat expectations by $0.04 per share or 11.76%. Investors might expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. There are currently 4 analysts covering this firm. Investors can look to their reports for more information. Shares of ACRX remained unchanged at $2.78. In the past year, the shares have traded as low as $2.78 and as high as $5.09. On average, 4212 shares of ACRX exchange hands on a given day and today's volume is recorded at 0.
Aastrom Biosciences, Inc (ASTM) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $-0.18 per share, and the company reported $-0.05 per share. Earnings were 72.22% larger than expected. An upside surprise. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. A total of 7 analysts are currently covering this company. Shares of ASTM fell by 0.76% or $-0.02/share to $2.62. In the past year, the shares have traded as low as $1.42 and as high as $4.45. On average, 262795 shares of ASTM exchange hands on a given day and today's volume is recorded at 45804.
Achillion Pharmaceuticals, Inc (ACHN) announced their most recent earnings results for the quarter ended in September 2011. The company reported $-0.15 per share when analysts were expecting earnings of $-0.17. Earnings beat analyst estimates by 11.76%. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. There are currently 11 analysts covering this firm. Investors can look to their reports for more information. Shares of ACHN fell by 1.44% or $-0.08/share to $5.49. In the past year, the shares have traded as low as $2.60 and as high as $8.95. On average, 547494 shares of ACHN exchange hands on a given day and today's volume is recorded at 44886.
Sajan Inc (SAJA) reported earnings results for the quarter ended September 2011. Analysts were expecting $0.01 per share, and the company reported $-0.01 per share. Earnings were unexpectedly -200.0% lower or $-0.02 per share below estimates. Investors could expect the stock price to fall as earnings were below expectations. Examining previous stock price movement may help to further determine the direction of the share price. Guidance, stock price, and revenue estimates must be considered as well. There is currently 1 analyst covering this firm. Investors can look to their reports for more information.
